Projects

A 3-arm, open-label, stratified randomized controlled trial with blinded end-point assessment to EValuate A Nitric oxidE generator (Nebivolol) as a diSease modifying mediCatioN in Diabetic Peripheral Neuropathy. (EVANESCENT-DPN RCT)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2026

Project Lead

Dr. Belinda George

Authors

Dr. Belinda

Project Status

ongoing

Project Type

ICMR